Vitamin K Market - By Type (Vitamin K1, Vitamin K2), By Application (Osteoporosis, Vitamin K-Dependent Clotting Factors Deficiency, Vitamin K Deficiency Bleeding), Route of Administration, Distribution Channel & forecast, 2023-2032

Vitamin K Market Size

Vitamin K Market size reached USD 839 million in 2022 and is estimated to witness 8.7% CAGR from 2023-2032. Surging burden of coagulation disorders to push industry growth.

The growing burden of chronic diseases, such as diabetes, arthritis, and cardiovascular diseases worldwide, along with the consequent adverse health impacts will drive vitamin K demand. As per estimates, more than 71 million individuals aged 50 and over are affected by at least one chronic disease in the U.S., with the number rising to over 142 million by 2050. The increasing prevalence of coagulation disorders driven by the adoption of unhealthy lifestyles as well as the deficiency of vitamin K will further foster the industry development.

Several adverse effects associated with vitamin K may pose as a major barrier for the vitamin K market expansion. The increasing incorporation of vitamin K as a supplement in diets may impact the normal functioning and lead to general body swelling and decreased appetite. The over-intake of vitamin K can also result in upset stomach and diarrhoea, further limiting the product demand.

Vitamin K Market Analysis

With respect to type, the vitamin K1 segment will observe 8.2% CAGR from 2023-2032 owing to the growing popularity of diet supplements. Vitamin K1 or phytonadione is a naturally occurring form of vitamin K sourced from green leafy vegetables. In addition to offering improved bone and heart health, it helps in the treatment of blood clotting disorders, such as hemorrhagic conditions in infants. The rising risk of fractures will further anchor the demand for vitamin K to improve bone density and support the maintenance of strong bones.

The vitamin K market share from the osteoporosis application segment exceeded USD 171 million in 2022. The growth can be attributed to the growing burden of osteoporosis as one of the leading chronic diseases affecting a large population across the globe. As per the US Surgeon General's report, nearly 10 million people aged 50 years and above in the U.S. suffer from osteoporosis. The growing focus on reducing the chances of bone fractures and the subsequently rising intake of vitamin K supplements will drive the industry expansion.

North America vitamin K market size will reach over USD 858 million by 2032 owing to the surging prevalence of chronic diseases and coagulation disorders. The higher intake of fast food mainly in the U.S. and Canada along with the increased healthcare expenditure has spurred the rising adoption of sedentary lifestyles in the region. The thriving unhealthy eating habits and the consequent deficiency of vital vitamins has steered the higher focus on R&D activities, further accelerating the consumption of vitamin K supplements. The increasing number of hospitals, growing government initiatives and the strong presence of pivotal pharmaceutical and nutraceutical industry players will also add to the regional market progress.

Vitamin K Market Share

Some of the leading vitamin K market contenders are

• NattoPharma ASA
• BASF SE
• Country Life,LLC (Kikkoman Corporation)
• Pfizer Inc.
• Amphastar Pharmaceuticals Inc.
• DSM
• Kappa Bioscience
• Livealth Biopharma Pvt. Ltd.
• NOW Foods
• Solgar Inc.

These firms are working on product approvals, acquisitions and several other strategies to sustain the rising competition.

Vitamin K Industry News

• Amphastar, in 2022, announced that the U.S. FDA approval of its new drug application for Epinephrine injection.
   
• BASF Pharma, in December 2022, revealed the acceptance of its excipient, namely Soluplus, into the FDA pilot program to assist novel excipients.
   

The vitamin K market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments:

Click here to Buy Section of this Report

By Type

• Vitamin K1
• Vitamin K2

By Application

• Osteoporosis
• Vitamin K-dependent clotting factors deficiency (VKCFD)
• Prothrombin deficiency
• Vitamin K Deficiency Bleeding (VKDB)
• Dermal applications
• Other applications

By Route of Administration

• Oral
  • Pills
  • Powders
  • Liquids
• Parenteral
• Topical

By Distribution Channel

• Offline
  • Hypermarkets/ Supermarket
  • Specialty stores
  • Pharmacy stores
• Online

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Switzerland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • Rest of Middle East & Africa